Showing results (111-120 of 182) with videos related to
Sort By:
Pageof 19
Breast Cancer Research and Treatment|May 31, 2019
Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapyMelissa Krystel-Whittemore, Jin Xu, Edi Brogi, et al.Journal of Clinical Pathology|July 4, 2014
Web based pathology assessment in RTOG 98-04Wendy A Woodward, Nour Sneige, Kathryn Winter, et al.Breast Cancer Research : BCR|November 21, 2013
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumorsClifford Hudis, Charles Swanton, Yelena Y Janjigian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 2, 2025
Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast CancerOtto Metzger Filho, Karla Ballman, Jordan Campbell, et al.Breast Cancer Research and Treatment|August 30, 2008
A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinomaSteven Sugarman, Carolyn Wasserheit, Elizabeth Hodgman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2007
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623Halle C F Moore, Stephanie J Green, Julie R Gralow, et al.Breast Cancer Research and Treatment|October 13, 2023
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patientsStephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.Nature Genetics|November 5, 2013
ESR1 ligand-binding domain mutations in hormone-resistant breast cancerWeiyi Toy, Yang Shen, Helen Won, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2012
Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101Lawrence N Shulman, Constance T Cirrincione, Donald A Berry, et al.Cancer|October 6, 2005
Developing a cancer-specific geriatric assessment: a feasibility studyArti Hurria, Supriya Gupta, Marjorie Zauderer, et al.Pageof 19